All eukaryotic cells with linear chromosomes face the problem of terminal DNA sequence loss that occurs as a result of either incomplete replication of the DNA strand synthesized by the lagging strand replication machinery or accidental collapse of the replication forks. If left unrepaired, these losses will eventually trigger the DNA damage response (DDR) and cell cycle arrest. Most eukaryotes use the enzyme telomerase that specializes in supplementing lost sequences at the chromosome ends to counteract this problem. Telomerase is minimally composed of the catalytic subunit, a telomerase reverse transcription, and the RNA component that serves as a scaffold for telomerase subunit assembly and also carries a region that templates the synthesis of telomeric DNA repeats. The template region of telomerase RNA determines both the guanine-rich sequence of telomeric repeats and the specificity of telomerase for chromosome ends because the template region has to anneal to the single-strand DNA (ssDNA) tail exposed at the site of its action. To further reinforce the specificity of telomerase for chromosome ends, a telomerase recruitment mechanism has evolved that relies on specialized proteins that bind telomeric ssDNA with high affinity and sequence specificity such as Cdc13 in budding yeast and POT1 in mammalian cells. However, in spite of these adaptations, telomerase does interfere with repair of DNA double strand breaks (DSBs) and may occasionally add telomeric repeats to either spontaneous or induced DSBs, a process known as chromosome healing by de novo telomere addition ([@bib6]). In this issue, Ouenzar et al. describe a novel mechanism that restricts the action of telomerase by spatial exclusion from sites of DNA repair.

Although de novo telomere addition at internal non-telomeric sites stabilizes the end of a broken chromosome, it leads to the loss of large portions of chromosome arms that usually endangers cell viability. Previous work in budding yeast identified molecular mechanisms responsible for curbing the action of telomerase on DSBs and uncovered that these mechanisms are intimately linked to DDR signaling ([@bib3]; [@bib10]). Upon detection of DSBs, Mec1 kinase, a budding yeast orthologue of ATR, initiates a signaling cascade by phosphorylating multiple targets. One of these targets phosphorylated in a *MEC1*-*RAD53*-*DUN1*--dependent manner is a Pif1 helicase, a known telomerase inhibitor that dislodges telomerase from its DNA substrate ([@bib2]). Importantly, this phosphorylation of Pif1 specifically mediates telomerase inhibition at DNA breaks, but not at telomeres ([@bib3]). In addition, activated Mec1 that accumulates at resected DNA ends directly phosphorylates Cdc13 on Ser 306, and this phosphorylation event prevents accumulation of Cdc13 at DNA ends with very short telomere-like sequence seeds, thereby suppressing telomere addition to accidental DSBs ([@bib10]). Although these sophisticated mechanisms elegantly incorporated into the DDR diminish the action of telomerase on DSBs, it appears to not be the whole story. Indeed, [@bib4] add a new layer of regulation to previous results by showing that telomerase action at DNA breaks is restricted by the sequestration of its RNA component in the nucleolus.

[@bib4] have used FISH to quantify intracellular distribution of *TLC1* RNA, a telomerase RNA in budding yeast, at different phases of the cell cycle. They found that individual telomerase RNA molecules formed foci in the nucleoplasm during the G1 and S phases of the cell cycle, but became sequestered in the nucleoli in the G2/M phase. Interestingly, the cell cycle--dependent trafficking of *TLC1* RNA into the nucleoli required Pif1 activity in the nucleoplasm, which removes telomerase from telomeres in late S/G2. The majority of DSBs in budding yeast are repaired by homologous recombination (HR), which is active in G2 phase and occurs exclusively in the nucleoplasm, suggesting that nucleolar localization of *TLC1* RNA could serve to reduce the interference of telomerase with HR in DSB repair. To interrogate a functional significance of nucleolar localization of *TLC1* RNA in the context of DSB repair, [@bib4] examined the distribution of *TLC1* RNA in the cells treated with bleomycin, a radiomimetic drug that generates DSBs. In bleomycin-treated cells in the G2/M phase, *TLC1* RNA redistributed slightly into the nucleoplasm, indicating that its trafficking between nucleoplasm and nucleolus is affected by DNA damage. Surprisingly, nucleolar localization of *TLC1* RNA was greatly reduced and most of the cells accumulated *TLC1* RNA foci in the nucleoplasm when HR was abolished by deletion of *RAD52*. This loss of nucleolar localization was a result of redistribution of *TLC1* RNA from the nucleolus into the nucleoplasm rather than its retention in the nucleoplasm because the cells arrested in G2/M with nocodazole still redistributed *TLC1* RNA into the nucleoplasm upon treatment with bleomycin. Importantly, *TLC1* RNA molecules that left nucleolus partially colocalized with persistent DSBs in the nucleoplasm highlighted by either Rfa1 or H2AX immunostaining. Whether the remaining *TLC1* RNAs that did not colocalize with DSBs were associated with telomeres remains to be determined.

To investigate the role of DDR in *TLC1* RNA trafficking, [@bib4] inactivated several factors that act upstream of Rad52. DSB resection is initiated by the MRX complex, and deletion of either the MRX component *MRE11* or *XRS2* completely suppressed the redistribution of *TLC1* RNA into the nucleoplasm in *rad52Δ* cells upon DNA damage. This suggests that the exit of *TLC1* RNA from the nucleolus could be triggered by DSB processing and the accumulation of ssDNA in the absence of Rad52. In support of this notion, inactivation of Tel1, which positively influences MRX activity at DSBs, also diminished accumulation of the *TLC1* RNA foci in the nucleoplasm, whereas inactivation of Mec1 had no effect. These results also suggest involvement of the ssDNA binding protein Cdc13, which recruits telomerase to both telomeres and DSB via its interaction with the Est1 subunit of telomerase complex ([@bib1]). Indeed, Cdc13 that is normally undetectable by immunofluorescence formed visible foci upon induction of DSBs, and these foci further increased in size in *rad52Δ* cells. Direct observation of Cdc13-GFP confirmed that it colocalizes with DSBs marked by Rfa1-mCherry in the majority of G2/M cells. Most importantly, a *cdc13-2* mutant that is proficient in ssDNA binding but fails to recruit telomerase completely suppressed the exit of *TLC1* RNA from nucleolus in bleomycin-treated *rad52Δ* cells in G2/M. This observation strongly implicated Est1--Cdc13 interaction in the nucleoplasmic accumulation of *TLC1* RNA after DNA damage.

Although excessive accumulation of ssDNA at the sites of DNA breaks and its enhanced binding by Cdc13 in the absence of Rad52 may trigger *TLC1* RNA redistribution into the nucleoplasm, the situation might be more complex. Time course experiments in *rad52Δ* cells demonstrated that initially only few *TLC1* RNA molecules exit the nucleolus and rapidly localize to DSBs in agreement with the aforementioned model, but later on the remaining *TLC1* RNA pool leaves the nucleolus and accumulates in the nucleoplasm but not at DSBs. What causes this second wave of *TLC1* RNA exit remains unknown, but possibly these *TLC1* RNA molecules associate with telomeres. Another puzzling finding is the effect of *RAD51* deletion, which resulted in disappearance of the Cdc13 foci and retention of the *TLC1* RNA in the nucleolus even in the *rad52Δ* cells, suggesting that somehow Rad51 promotes accumulation of Cdc13 at DSBs. Reduced binding of Cdc13 to irreparable HO-induced DSB in *rad51Δ* cells has been previously reported ([@bib5]), but the reason behind it remains unknown. One possibility is that the presence of Rad51 may have an impact on the competition between RPA and Cdc13 for ssDNA binding in favor of the latter.

In search of the regulators of the cell cycle--dependent *TLC1* RNA trafficking, [@bib4] turned to SUMOylation, a well-known modulator of the DDR, which affects both the intranuclear distribution and function of several HR and telomere proteins. Although deletion of either *SIZ1* or *SIZ2* genes encoding two homologous SUMO E3 ligases had no effect on cell cycle--dependent *TLC1* RNA trafficking between the nucleoplasm and nucleolus in the absence of DNA damage, it did so when DNA damage was induced with bleomycin. Specifically, the deletion of *SIZ1* strongly decreased accumulation of *TLC1* RNA in the nucleoplasm of *rad52Δ* cells, thus implicating Siz1 in the control of spatial distribution of *TLC1* RNA after DNA damage ([Fig. 1](#fig1){ref-type="fig"}). Further analysis revealed that Siz1 is neither involved in DSB processing nor Cdc13 accumulation at resected DSBs but rather acts downstream of these events. The identity of downstream targets of Siz1-dependent SUMOylation, which promote *TLC1* RNA exit from nucleolus in response to DNA damage, remains to be established.

![**Several mechanisms promote telomerase exclusion from DSBs in G2/M.** (A) In wild-type cells, Mec1 activated at DSBs phosphorylates both Pif1 and Cdc13. Phosphorylated Pif1 specifically inhibits telomerase action at DSBs, whereas phosphorylation of Cdc13 limits its accumulation at resected DSBs. In addition, most of the telomerase (Est2-TLC1-Est1) is sequestered in the nucleolus by a yet unknown anchor. These three mechanisms prevent de novo telomere addition at DSBs. (B) In Pif1-deficient cells, telomerase exits the nucleolus in a Siz1-dependent manner and telomerase action is no longer prevented at DSBs. This increases the chance of telomerase recruitment to DSBs via an Est1--Cdc13 interaction.](JCB_201705156_Fig1){#fig1}

To address a functional role of *TLC1* RNA trafficking in de novo telomere addition at spontaneous DSBs, [@bib4] performed a series of gross chromosomal rearrangement (GCR) assays in a set of mutants that predictably affect *TLC1* RNA trafficking, and then quantified the number of GCR events corresponding to telomere healing. The results of these assays demonstrated that Siz1-dependent SUMOylation is indeed required for de novo telomere addition in the absence of Rad52, but it becomes largely dispensable when Pif1 activity in the nucleoplasm is reduced. Finally, using paired-end sequencing, [@bib4] revealed that de novo telomere addition in bleomycin-treated yeast occurred downstream of short (\<10 nucleotides) TG-rich sequences and that *RAD52* deletion increases de novo telomere addition. They also found that a high percentage of de novo telomere addition occurred at the ribosomal DNA locus, but it remains unclear whether this reflects telomerase activity in the nucleolus or not because broken ribosomal DNA relocalizes to the nucleoplasm for HR-mediated repair ([@bib8]).

The study by [@bib4] clearly demonstrates that spatial segregation of the telomerase and HR activities is another mechanism that minimizes the odds of telomere addition to accidental DSBs ([Fig. 1](#fig1){ref-type="fig"}). It also raises a number of questions requiring further investigation. It is not yet clear what triggers TLC1 exit from the nucleolus in the absence of Rad52. Possibly, DNA damage persists when HR is dysfunctional, leading to increased SUMOylation and eventually Siz1-dependent exit of TLC1. Another intriguing question is the mechanism responsible for G2/M phase--specific sequestration of *TLC1* RNA in the nucleolus. The nucleolus is now recognized as a multifunctional cellular compartment, with functions beyond its role in ribosome subunit assembly. It exerts its multiple functions in part via sequestration of the regulatory proteins; a prominent example in yeast being the cell cycle regulator Cdc14. Because the nucleolus is not membrane bound and nucleolar localization signals are not well defined, many molecules freely enter and leave the nucleolus by diffusion. It is believed that retention or sequestration of molecules occurs primarily as a function of their affinity for the anchored resident proteins, such as nucleolin and nucleophosmin. These affinities, and hence the stability of the interactions, could be regulated by posttranslational modifications in a cell cycle--dependent manner. *TLC1* RNA retention in the nucleolus is clearly cell cycle regulated, and its retention in the nucleolus might result from anchoring via other subunits of the telomerase complex. Interestingly, both telomerase components Est2 and Est1 localize to the nucleolus when overexpressed but become nucleoplasmic upon overexpression of TLC1 ([@bib7]). Human telomerase also localizes to the nucleolus where its assembly takes place, but in contrast to its yeast counterpart remains in the nucleolus during most of the cell cycle and is released only when telomeres are replicated ([@bib9]). Nevertheless, the nucleolar association of human telomerase is enhanced after DNA damage, thus the aspect of spatial separation of telomerase and HR activity appears to be conserved from yeast to humans.
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